These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1556117)

  • 1. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
    Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
    J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.
    Gitay-Goren H; Halaban R; Neufeld G
    Biochem Biophys Res Commun; 1993 Feb; 190(3):702-8. PubMed ID: 8439321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
    Soker S; Svahn CM; Neufeld G
    J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
    Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
    J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
    Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of vascular permeability factor to endothelial cells.
    Olander JV; Connolly DT; DeLarco JE
    Biochem Biophys Res Commun; 1991 Feb; 175(1):68-76. PubMed ID: 1998521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the receptors for vascular endothelial growth factor.
    Vaisman N; Gospodarowicz D; Neufeld G
    J Biol Chem; 1990 Nov; 265(32):19461-6. PubMed ID: 2246236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
    Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
    Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and its receptors.
    Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
    Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
    J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.
    Jakeman LB; Winer J; Bennett GL; Altar CA; Ferrara N
    J Clin Invest; 1992 Jan; 89(1):244-53. PubMed ID: 1729274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
    Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
    J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.
    Peretz D; Gitay-Goren H; Safran M; Kimmel N; Gospodarowicz D; Neufeld G
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1340-7. PubMed ID: 1540178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
    Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.